AIC
RDY icon

Ameritas Investment Company’s Dr. Reddy's Laboratories RDY Stock Holding History

Ameritas Investment Company’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,635
Closed -$56.9K – 1768
2021
Q1 		$56.9K Buy
+4,635
New +$59.5K ﹤0.01% 915
2019
Q4 		– Sell
-155
Closed -$1K – 1345
2019
Q3 		$1K Buy
+155
New +$1.15K ﹤0.01% 1587

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Ameritas Investment Company's RDY Position: Q2 2021 in Review

Ameritas Investment Company sold out of Dr. Reddy's Laboratories (RDY) in Q2 2021, closing a stake of 4,635 shares — an estimated $56.9K sold.

Ameritas Investment Company first reported a position in RDY in Q3 2019 and held it in 2 quarters. The position peaked at $56.9K in Q1 2021. 161 funds tracked by Wall St. Rank hold RDY as of Q2 2021.

  • Ameritas Investment Company reported no remaining Dr. Reddy's Laboratories position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 4,635 Dr. Reddy's Laboratories shares in Q2 2021, an estimated $56.9K.
  • Ameritas Investment Company first reported a position in Dr. Reddy's Laboratories in Q3 2019 and held it in 2 quarters.
  • Ameritas Investment Company's Dr. Reddy's Laboratories position peaked at $56.9K in Q1 2021.
  • 161 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.